πŸ‡ΊπŸ‡Έ FDA
Patent

US 6933129

Method for culturing and assaying cells

expired A61PA61P17/02A61P31/00

Quick answer

US patent 6933129 (Method for culturing and assaying cells) held by Precision Therapeutics, Inc. expires Mon Aug 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Precision Therapeutics, Inc.
Grant date
Tue Aug 23 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61P, A61P17/02, A61P31/00, A61P35/00, A61P37/02